{"id":31235,"date":"2025-06-19T14:24:21","date_gmt":"2025-06-19T12:24:21","guid":{"rendered":"https:\/\/vilkaviskiovsb.lt\/?p=31235"},"modified":"2025-06-19T14:24:21","modified_gmt":"2025-06-19T12:24:21","slug":"papildyti-narkotiniu-ir-psichotropiniu-medziagu-sarasai-2","status":"publish","type":"post","link":"https:\/\/vilkaviskiovsb.lt\/en\/2025\/06\/19\/papildyti-narkotiniu-ir-psichotropiniu-medziagu-sarasai-2\/","title":{"rendered":"Papildyti Narkotini\u0173 ir psichotropini\u0173 med\u017eiag\u0173 s\u0105ra\u0161ai"},"content":{"rendered":"<div class=\"info-block__wrap clearfix\">\n<p>Narkotik\u0173, tabako ir alkoholio kontrol\u0117s departamentas (toliau &#8211; NTAKD) informuoja, kad <a href=\"https:\/\/www.e-tar.lt\/portal\/lt\/legalAct\/d3c7aa204b7511f0b070ee7f1ceefc75\">Lietuvos Respublikos sveikatos apsaugos ministro 2025 m. bir\u017eelio 17 d. \u012fsakymu Nr. V-571<\/a> Narkotini\u0173 ir psichotropini\u0173 med\u017eiag\u0173 s\u0105ra\u0161ai buvo papildyti 11 nauj\u0173 med\u017eiag\u0173, t.y. \u0161ioms med\u017eiagoms buvo pritaikytos rinkos ribojimo priemon\u0117s Lietuvoje (<a href=\"https:\/\/www.e-tar.lt\/portal\/lt\/legalAct\/d3c7aa204b7511f0b070ee7f1ceefc75\">https:\/\/www.e-tar.lt\/portal\/lt\/legalAct\/d3c7aa204b7511f0b070ee7f1ceefc75<\/a> ).<\/p>\n<p>\u0160ie Narkotini\u0173 ir psichotropini\u0173 med\u017eiag\u0173 s\u0105ra\u0161\u0173 pakeitimai padaryti atsi\u017evelgiant \u012f besikei\u010dian\u010dias narkotini\u0173 ir psichotropini\u0173 med\u017eiag\u0173 pasi\u016blos tendencijas Europoje bei siekiant suma\u017einti galimyb\u0119 patekti naujoms psichoaktyv\u0173 efekt\u0105 sukelian\u010dioms med\u017eiagoms \u012f legali\u0105 rink\u0105 ir taip apsaugoti visuomen\u0119 nuo labai pavojing\u0173 med\u017eiag\u0173 pasi\u016blos ir spartaus i\u0161plitimo.<\/p>\n<p>\u012evertinus \u0161i\u0173 nauj\u0173 psichoaktyvi\u0173j\u0173 med\u017eiag\u0173 keliam\u0105 rizik\u0105, Departamentas pasi\u016bl\u0117 Lietuvos Respublikos sveikatos apsaugos ministerijai papildyti Narkotini\u0173 ir psichotropini\u0173 med\u017eiag\u0173 s\u0105ra\u0161us ir \u012ftraukti 11 nauj\u0173 psichoaktyvi\u0173j\u0173 med\u017eiag\u0173, kurios nesenai buvo identifikuotas Europos rinkoje:<\/p>\n<ul>\n<li>9 med\u017eiagos buvo \u012ftrauktos \u012f I-\u0105j\u012f Narkotini\u0173 ir psichotropini\u0173 med\u017eiag\u0173 s\u0105ra\u0161\u0105 individualiais pavadinimais: <strong>1P-AL-LAD; 1S-LSD; delta-9-THC-O-acetate; 10-OH-HHC; 10-OH-HHC-P; delta-9-THC-methylcarbonate; Homomazindol; Cychlorphine; Spirochlorphine<\/strong>.<\/li>\n<li>2 med\u017eiagos buvo \u012ftrauktos \u012f darini\u0173 grupes:\n<ul>\n<li><strong>Ro 07-3953<\/strong> \u012ftraukta \u012f Benzodiazepino ir jo bioizosterini\u0173 darini\u0173 grup\u0119;<\/li>\n<li><strong>4&#8242;-Ph-PVP<\/strong> \u012ftraukta \u012f Pirovalerono darini\u0173 ir pirovalerono bioizosterini\u0173 darini\u0173 grup\u0119.<\/li>\n<\/ul>\n<\/li>\n<li>6 naujos Europos rinkoje nustatytos psichoaktyviosios med\u017eiagos jau kontroliuojamos pagal ankstesnius Narkotini\u0173 ir psichotropini\u0173 med\u017eiag\u0173 s\u0105ra\u0161\u0173 papildymus ir patenka \u012f darini\u0173 grupes:\n<ul>\n<li><strong>Desnitroclonitazene<\/strong> patenka \u012f Benzimidazolo darini\u0173 grup\u0119;<\/li>\n<li><strong>MDMB-4en-P-5Br-INACA, CUMYL-EINACA<\/strong> patenka \u012f Sintetini\u0173 kanabinoid\u0173 darini\u0173 grup\u0117s 1 pogrup\u012f;<\/li>\n<li><strong>N-isopropylnorbutylone, 3,4-EtMC<\/strong> patenka \u012f Katinono darini\u0173 ir katinono bioizosterini\u0173 darini\u0173 grup\u0119;<\/li>\n<li><strong>Pyrophenidone<\/strong> patenka \u012f Pirovalerono ir jo bioizosterini\u0173 darini\u0173 grup\u0119.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p>Nuo 2010 m. Lietuvoje \u012fsigalioj\u0119s narkotini\u0173 ir psichotropini\u0173 med\u017eiag\u0173 reglamentavimas, kuomet med\u017eiagos \u012f Narkotini\u0173 ir psichotropini\u0173 med\u017eiag\u0173 s\u0105ra\u0161us \u012ftraukiamos ne tik individualiais pavadinimais, bet ir \u012f darini\u0173 grupes, leid\u017eia rinkos ribojimo priemones naujoms psichoaktyviosioms med\u017eiagoms pritaikyti \u017eenkliai grei\u010diau ir patogiau, t.y. jeigu naujai nustatytos psichoaktyviosios med\u017eiagos chemin\u0117 strukt\u016bra atitinka kurios nors vienos Narkotini\u0173 ir psichotropini\u0173 med\u017eiag\u0173 s\u0105ra\u0161uose esan\u010dios darini\u0173 grup\u0117s apra\u0161ym\u0105, ji automati\u0161kai pakli\u016bva \u012f \u0161iuos s\u0105ra\u0161us ir tampa kontroliuojama Lietuvoje.<\/p>\n<p>Kasmet Europoje atsiranda nauj\u0173 psichoaktyvi\u0173j\u0173 med\u017eiag\u0173 (angl. <em>new psychoactive substances<\/em>, NPS), kei\u010dian\u010di\u0173 seniai \u017einomas \u201etradicines\u201c narkotines ir psichotropines med\u017eiagas. Tokia vis besiple\u010dianti ir vis kintanti nauj\u0173 med\u017eiag\u0173 rinka kelia didel\u012f susir\u016bpinim\u0105, tod\u0117l\u00a0 siekiant ma\u017einti j\u0173 prieinamum\u0105 bei pasi\u016bl\u0105 naujos psichoaktyviosios med\u017eiagos yra \u012ftraukiamos \u012f Narkotini\u0173 ir psichotropini\u0173 med\u017eiag\u0173 s\u0105ra\u0161us Lietuvoje.<\/p>\n<p>NTAKD atkreipia d\u0117mes\u012f, kad da\u017enai vartotojai gali ne\u017einoti, k\u0105 vartoja, tod\u0117l kyla didesn\u0117 gr\u0117sm\u0117 \u017emogaus sveikatai bei mirtinam apsinuodijimui, tod\u0117l raginame visuomen\u0119 b\u016bti atsargiems.<\/p>\n<p>J\u016bs\u0173 patogumui, i\u0161samesn\u0119 informacij\u0105 apie konkre\u010dias narkotines ir psichotropines med\u017eiagas, kontroliuojamas Lietuvoje, galite rasti adresu <a href=\"https:\/\/visuomene.ntakd.lt\/\">https:\/\/visuomene.ntakd.lt<\/a>\/. Pateikta informacija prieinama tik registruotiems vartotojams.<\/p>\n<p>Primename, kad u\u017e neteis\u0117t\u0105 disponavim\u0105 narkotin\u0117mis ir psichotropin\u0117mis med\u017eiagomis yra numatyta baud\u017eiamoji atsakomyb\u0117.<\/p>\n<\/div>\n<p>NTAKD informacija<\/p>\n<div class=\"info-block__wrap clearfix\">\n<p>Atnaujinimo data: 2025-06-19<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>Narkotik\u0173, tabako ir alkoholio kontrol\u0117s departamentas (toliau &#8211; NTAKD) informuoja, kad Lietuvos Respublikos sveikatos apsaugos ministro 2025 m. bir\u017eelio 17 d. \u012fsakymu Nr. V-571 Narkotini\u0173 ir psichotropini\u0173 med\u017eiag\u0173 s\u0105ra\u0161ai buvo papildyti 11 nauj\u0173 med\u017eiag\u0173, t.y. \u0161ioms med\u017eiagoms buvo pritaikytos rinkos ribojimo priemon\u0117s Lietuvoje (https:\/\/www.e-tar.lt\/portal\/lt\/legalAct\/d3c7aa204b7511f0b070ee7f1ceefc75 ). \u0160ie Narkotini\u0173 ir psichotropini\u0173 med\u017eiag\u0173 s\u0105ra\u0161\u0173 pakeitimai padaryti atsi\u017evelgiant \u012f&hellip;<\/p>","protected":false},"author":3,"featured_media":31236,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2},"jetpack_post_was_ever_published":false},"categories":[6],"tags":[],"class_list":["post-31235","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-naujienos","category-6","description-off"],"jetpack_publicize_connections":[],"jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/p7kWFe-87N","jetpack_featured_media_url":"https:\/\/vilkaviskiovsb.lt\/wp-content\/uploads\/2025\/06\/TsUdjX61MSda.jpg","post_mailing_queue_ids":[],"_links":{"self":[{"href":"https:\/\/vilkaviskiovsb.lt\/en\/wp-json\/wp\/v2\/posts\/31235","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/vilkaviskiovsb.lt\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/vilkaviskiovsb.lt\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/vilkaviskiovsb.lt\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/vilkaviskiovsb.lt\/en\/wp-json\/wp\/v2\/comments?post=31235"}],"version-history":[{"count":1,"href":"https:\/\/vilkaviskiovsb.lt\/en\/wp-json\/wp\/v2\/posts\/31235\/revisions"}],"predecessor-version":[{"id":31237,"href":"https:\/\/vilkaviskiovsb.lt\/en\/wp-json\/wp\/v2\/posts\/31235\/revisions\/31237"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/vilkaviskiovsb.lt\/en\/wp-json\/wp\/v2\/media\/31236"}],"wp:attachment":[{"href":"https:\/\/vilkaviskiovsb.lt\/en\/wp-json\/wp\/v2\/media?parent=31235"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/vilkaviskiovsb.lt\/en\/wp-json\/wp\/v2\/categories?post=31235"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/vilkaviskiovsb.lt\/en\/wp-json\/wp\/v2\/tags?post=31235"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}